Published in:
Open Access
01-12-2010 | Urology – Original Paper
New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT
Authors:
Shoichi Iida, Hideki Ishida, Tadahiko Tokumoto, Kazuya Omoto, Hiroki Shirakawa, Tomokazu Shimizu, Hiroyuki Amano, Kiyoshi Setoguchi, Taiji Nozaki, Daisuke Toki, Daisuke Tokita, Kazunari Tanabe
Published in:
International Urology and Nephrology
|
Issue 4/2010
Login to get access
Abstract
Background
To evaluate the role of the oral glucose tolerance test (OGTT) before transplantation and to examine the risk factors for new-onset diabetes after transplantation (NODAT) during long-term follow-up of renal transplant recipients receiving FK-based therapy.
Methods
The study evaluated 378 patients pre-transplantation using the OGTT and assigned them to one of three groups: Group 1, normal pattern; Group 2, impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) pattern (IFG/IGT); and Group 3, DM pattern.
Results
Although the incidence of NODAT was higher in Group 3 than in groups 1 and 2, no significant difference was found between the three groups with regard to graft survival during long-term follow-up. Multivariate analysis showed that only a family history of diabetes was a significant factor determining NODAT progression.
Conclusions
Impaired glucose tolerance appears to be a threshold influencing NODAT; however, it was not a significant factor in graft survival. Careful monitoring and management based on the result of the pre-transplantation OGTT appear to prevent the deterioration of impaired glucose tolerance in renal transplant recipients receiving FK-based therapy, even when a pre-operative OGTT shows impaired glycemic control.